Home Pharmac

Pharmac

Auto Added by WPeMatico

Delay in decision on modifying funded access to mifepristone and misoprostol proposal

Source: Pharmac PHARMAC would like to advise all interested parties that there will be a delay in the decision on a proposal to list mifepristone in...

OIA response: Vinorelbine

Source: Pharmac 31 March 2020    Dear   REQUEST FOR INFORMATION  Thank you for your email of 3 March 2020, requesting information under the Official Information Act 1982 (OIA). ...

March 2020 tender notification

Source: Pharmac Alfacalcidol Cap 0.25 mcg Alfacalcidol Cap 1 mcg Alfacalcidol Oral drops 2 mcg per ml Alprostadil Inj 10 mcg Alprostadil Inj 20 mcg Betamethasone Dipropionate Crm 0.05% in propylene glycol base Betamethasone Dipropionate Oint 0.05% in...

Decision to fund ivacaftor (Kalydeco) for people with cystic fibrosis with the G551D mutation

Source: Pharmac What we’re doing We are pleased to announce a decision to fund ivacaftor (Kalydeco) for the treatment of people with cystic fibrosis with the...

Decision to change the funded brand of labetalol tablets

Source: Pharmac What we’re doing PHARMAC has made a decision to make changes to the funded brand of labetalol tablets, which may be used in the...

RFP – supply of diabetes agents: SGLT-2 inhibitors, GLP-1 agonists and DPP-4 inhibitors –...

Source: Pharmac If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz(external link)) no...

Decision to list medical devices supplied by Hologic (Australia & New Zealand) Pty Limited

Source: Pharmac Our response to what you told us We appreciate the time people took to respond to this consultation. A summary of the main themes raised...

Popular News